Showing results (441-450 of 484) with videos related to
Sort By:
Pageof 49
Journal of the National Cancer Institute|November 18, 2000
Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinomaK Kawakami, J Brabender, R V Lord, et al.Oncotarget|November 20, 2020
Phase I trial of TRC102 (methoxyamine HCl) in combination with temozolomide in patients with relapsed solid tumors and lymphomasGeraldine O'Sullivan Coyne, Shivaani Kummar, Robert S Meehan, et al.Cell|April 7, 2018
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of CancerKatherine A Hoadley, Christina Yau, Toshinori Hinoue, et al.Genome Research|February 5, 2015
Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolutionHoon Kim, Siyuan Zheng, Seyed S Amini, et al.Nature Genetics|May 12, 2025
Three-dimensional genome landscape of primary human cancersKathryn E Yost, Yanding Zhao, King L Hung, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 15, 2015
Association of the colorectal CpG island methylator phenotype with molecular features, risk factors, and family historyDaniel J Weisenberger, A Joan Levine, Tiffany I Long, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2016
Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer StudyRoisin M Connolly, Huili Li, Rachel C Jankowitz, et al.Oncotarget|October 29, 2013
Alterations of immune response of Non-Small Cell Lung Cancer with AzacytidineJohn Wrangle, Wei Wang, Alexander Koch, et al.Nature Genetics|August 22, 2017
A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancerPaz Polak, Jaegil Kim, Lior Z Braunstein, et al.Science (New York, N.Y.)|October 27, 2018
The chromatin accessibility landscape of primary human cancersM Ryan Corces, Jeffrey M Granja, Shadi Shams, et al.Pageof 49